Anxiety Disorders Withdrawn Phase 1 Trials for LY-2456302 (DB12341)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02218775FASTMAS (Fast-Fail Trials in Mood and Anxiety Spectrum Disorders) Kappa Opioid Receptor Phase 1 StudyHealth Services Research